Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Autoregulation and Severe Coronavirus Disease 19 [CA-COVID]: a Single-center Physiological Study

NCT04930874 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT04930874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Autoregulation and Severe Coronavirus Disease 19 [CA-COVID]: a Single-center Physiological Study
Lead sponsor
University of Athens
Phase
Not applicable
Overall status
Terminated
Start date
June 22, 2021
Completion date
September 16, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome, covid-19 pneumonia